Capital World Investors’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-3
| Closed | – | – | 532 |
|
|
2020
Q1 | $0 | Sell |
3
-2,493,175
| -100% | – | ﹤0.01% | 526 |
|
|
2019
Q4 | $211M | Buy |
2,493,178
+1,392
| +0.1% | +$118K | 0.05% | 247 |
|
|
2019
Q3 | $168M | Buy |
2,491,786
+65,704
| +3% | +$4.43M | 0.04% | 257 |
|
|
2019
Q2 | $208M | Buy |
2,426,082
+872,055
| +56% | +$74.7M | 0.05% | 245 |
|
|
2019
Q1 | $138M | Buy |
1,554,027
+336,000
| +28% | +$29.8M | 0.03% | 275 |
|
|
2018
Q4 | $104M | Sell |
1,218,027
-1,243,814
| -51% | -$106M | 0.03% | 281 |
|
|
2018
Q3 | $239M | Buy |
2,461,841
+628,738
| +34% | +$61M | 0.06% | 227 |
|
|
2018
Q2 | $173M | Buy |
1,833,103
+158,184
| +9% | +$14.9M | 0.04% | 257 |
|
|
2018
Q1 | $136M | Buy |
1,674,919
+220,309
| +15% | +$17.9M | 0.03% | 262 |
|
|
2017
Q4 | $130M | Buy |
1,454,610
+227,456
| +19% | +$20.3M | 0.03% | 277 |
|
|
2017
Q3 | $114M | Buy |
1,227,154
+813,133
| +196% | +$75.7M | 0.03% | 278 |
|
|
2017
Q2 | $37.6M | Buy |
414,021
+3,286
| +0.8% | +$298K | 0.01% | 368 |
|
|
2017
Q1 | $36.1M | Buy |
+410,735
| New | +$36.1M | 0.01% | 377 |
|
|
2014
Q2 | – | Sell |
-1,120,000
| Closed | -$76.4M | – | 517 |
|
|
2014
Q1 | $76.4M | Sell |
1,120,000
-350,000
| -24% | -$23.9M | 0.02% | 316 |
|
|
2013
Q4 | $103M | Sell |
1,470,000
-140,700
| -9% | -$9.89M | 0.03% | 293 |
|
|
2013
Q3 | $116M | Sell |
1,610,700
-2,067,525
| -56% | -$149M | 0.04% | 287 |
|
|
2013
Q2 | $205M | Buy |
+3,678,225
| New | +$205M | 0.07% | 230 |
|